Literature DB >> 20045077

OPA1 (dys)functions.

Thomas Landes1, Ingrid Leroy, Ambre Bertholet, Alan Diot, Farnoosh Khosrobakhsh, Marlène Daloyau, Noélie Davezac, Marie-Christine Miquel, Delphine Courilleau, Emmanuelle Guillou, Aurélien Olichon, Guy Lenaers, Laetitia Arnauné-Pelloquin, Laurent J Emorine, Pascale Belenguer.   

Abstract

Mitochondrial morphology varies according to cell type and cellular context from an interconnected filamentous network to isolated dots. This morphological plasticity depends on mitochondrial dynamics, a balance between antagonistic forces of fission and fusion. DRP1 and FIS1 control mitochondrial outer membrane fission and Mitofusins its fusion. This review focuses on OPA1, one of the few known actors of inner membrane dynamics, whose mutations provoke an optic neuropathy. Since its first identification in 2000 the characterization of the functions of OPA1 has made rapid progress thus providing numerous clues to unravel the pathogenetic mechanisms of ADOA-1. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20045077     DOI: 10.1016/j.semcdb.2009.12.012

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  27 in total

Review 1.  Cell signaling and mitochondrial dynamics: Implications for neuronal function and neurodegenerative disease.

Authors:  Theodore J Wilson; Andrew M Slupe; Stefan Strack
Journal:  Neurobiol Dis       Date:  2012-01-24       Impact factor: 5.996

2.  The BH3-only Bnip3 binds to the dynamin Opa1 to promote mitochondrial fragmentation and apoptosis by distinct mechanisms.

Authors:  Thomas Landes; Laurent J Emorine; Delphine Courilleau; Manuel Rojo; Pascale Belenguer; Laetitia Arnauné-Pelloquin
Journal:  EMBO Rep       Date:  2010-04-30       Impact factor: 8.807

Review 3.  Mitochondrial dynamics: the intersection of form and function.

Authors:  Andrew Ferree; Orian Shirihai
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

4.  Clinical and genetic features of eight Chinese autosomal-dominant optic atrophy pedigrees with six novel OPA1 pathogenic variants.

Authors:  Huajin Li; Evan M Jones; Hui Li; Lizhu Yang; Zixi Sun; Zhisheng Yuan; Rui Chen; Fangtian Dong; Ruifang Sui
Journal:  Ophthalmic Genet       Date:  2018-06-28       Impact factor: 1.803

5.  Loss of mitochondrial protease OMA1 alters processing of the GTPase OPA1 and causes obesity and defective thermogenesis in mice.

Authors:  Pedro M Quirós; Andrew J Ramsay; David Sala; Erika Fernández-Vizarra; Francisco Rodríguez; Juan R Peinado; Maria Soledad Fernández-García; José A Vega; José A Enríquez; Antonio Zorzano; Carlos López-Otín
Journal:  EMBO J       Date:  2012-03-20       Impact factor: 11.598

Review 6.  Resolving presynaptic structure by electron tomography.

Authors:  Guy A Perkins; Dakota R Jackson; George A Spirou
Journal:  Synapse       Date:  2015-03-09       Impact factor: 2.562

7.  OMA1 mediates OPA1 proteolysis and mitochondrial fragmentation in experimental models of ischemic kidney injury.

Authors:  Xiao Xiao; Yanzhong Hu; Pedro M Quirós; Qingqing Wei; Carlos López-Otín; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2014-03-26

8.  The short variant of optic atrophy 1 (OPA1) improves cell survival under oxidative stress.

Authors:  Hakjoo Lee; Sylvia B Smith; Shey-Shing Sheu; Yisang Yoon
Journal:  J Biol Chem       Date:  2020-04-03       Impact factor: 5.157

9.  N-terminal cleavage of the mitochondrial fusion GTPase OPA1 occurs via a caspase-independent mechanism in cerebellar granule neurons exposed to oxidative or nitrosative stress.

Authors:  Josie J Gray; Amelia E Zommer; Ron J Bouchard; Nathan Duval; Craig Blackstone; Daniel A Linseman
Journal:  Brain Res       Date:  2012-12-07       Impact factor: 3.252

10.  Drosophila male-sterile mutation emmenthal specifically affects the mitochondrial morphogenesis.

Authors:  N V Dorogova; E U Bolobolova; K A Akhmetova; S A Fedorova
Journal:  Protoplasma       Date:  2012-07-26       Impact factor: 3.356

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.